- Passage Bio press release (NASDAQ:PASG): FY GAAP EPS of -$1.86 beats by $0.04.
- Cash, cash equivalents and marketable securities were $114.3 million as of December 31, 2023, as compared to $189.6 million as of December 31, 2022. The company expects current cash, cash equivalents and marketable securities to fund operations into Q4 2025.
Passage Bio GAAP EPS of -$1.86 beats by $0.04
Recommended For You
More Trending News
About PASG Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PASG | - | - |
| Passage Bio, Inc. | ||